(CODX) – Company Press Releases
-
Co-Diagnostics, Inc. to Participate in Gilmartin Group Annual Emerging Growth Showcase on Sept 21
-
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023
-
Co-Diagnostics, Inc. Appoints Chief Regulatory Affairs Officer
-
Co-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C.
-
Co-Diagnostics, Inc. to Host Booth at Medlab Asia Conference in Bangkok, Thailand
-
Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results
-
Co-Diagnostics, Inc. Announces Second Quarter 2023 Earnings Release Date and Webcast
-
Co-Diagnostics, Inc. to Host Booth and Discuss Recent Grant Awards at AACC 2023 in Anaheim, CA
-
Co-Diagnostics, Inc. Announces Recent Grant Awards
-
Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program
-
Co-Diagnostics, Inc. Reports First Quarter 2023 Financial Results
-
Co-Diagnostics, Inc. to Host Booth at Senior Living Executive Conference in New Orleans, LA
-
Co-Diagnostics, Inc. Announces First Quarter 2023 Earnings Release Date and Webcast
-
Co-Diagnostics, Inc. to Host Booth at 67th Annual CARPHA Conference April 27-29
-
Co-Diagnostics, Inc. to Host Booth at ECCMID 2023 April 15-18 in Copenhagen, Denmark
-
Co-Diagnostics, Inc. to Host Booth at 10th Gene Quantification Event in Munich, Germany, March 20-22
-
Co-Diagnostics, Inc. Reports Full Year 2022 Financial Results
-
CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 EARNINGS RELEASE DATE AND WEBCAST
-
Co-Diagnostics, Inc. to Present and Host Booth at TRI-CON in San Diego, CA, March 6-8
-
Co-Diagnostics, Inc. to Host Booth at 89th Annual AMCA Conference in Reno, NV on Feb 28-March 3
-
Co-Diagnostics, Inc. Initiates Clinical Evaluations for its At-Home and Point-of-Care Co-Dx PCR Home™ Platform
-
Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2023 in Dubai on February 6-9
-
Co-Diagnostics, Inc. Commemorates Third Anniversary of the Completion of its First COVID-19 Test Design
-
Co-Diagnostics, Inc. to Host Booth at CES 2023 January 5-8
-
Co-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022
-
Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany
-
Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results
-
Co-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ
-
Co-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer
-
CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST
-
Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa
-
Co-Diagnostics, Inc. to Host Booths at Conferences in Washington, D.C. and Bangkok, Thailand
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kiromic, LifeStance, MINISO, and Co-Dx and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Co-Dx, Ampio, Sinovac, and Lottery.com and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
-
Co-Diagnostics, Inc. to Sponsor, Present, and Host Booth at 66th Annual CARPHA Conference on Sept 15-17 in Jamaica
-
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Co-Dx, Ampio, Sinovac, and Lottery.com and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tuya, LifeStance, MINISO, and Co-Dx and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tuya, LifeStance, MINISO, and Co-Dx and Encourages Investors to Contact the Firm
-
Co-Diagnostics, Inc. to Host Booth at Medical Fair Asia 2022 in Singapore on Aug 31-Sep 2
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Co-Dx, Ampio, and Lottery.com and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, and Ampio and Encourages Investors to Contact the Firm
-
Co-Diagnostics, Inc. to Present at 14th Next Generation Dx Summit in Washington, D.C.
-
Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
-
/C O R R E C T I O N -- Co-Diagnostics/
Back to CODX Stock Lookup
